R-Pharm US
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 3096, Princeton, New Jersey, 0854...Phone Number
(609) 512-1739Website
www.rpharm-us.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About R-Pharm US
R-PHARM US is a fully integrated specialty pharmaceutical company established in 2014 and located in Princeton, NJ. The company focuses on the development and commercialization of specialty medicines for the treatment of cancer and chronic immune diseases. Notably, R-PHARM US acquired IXEMPRA (ixabepilone) from Bristol-Myers Squibb, successfully treating over 20,000 metastatic breast cancer patients in the past six years. Their intended clients include patients suffering from cancer and chronic immune diseases.Explore more
R-Pharm US Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is R-Pharm US your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at R-Pharm US
Funding: Get notified immidiatlly once R-Pharm US has new funding data
Check out if R-Pharm US is spiking on competitors!
Click to see if R-Pharm US had a recent Job posting/layoffs
Check if R-Pharm US has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when R-Pharm US launches new products
Earning: See what the market has to say on R-Pharm US recently announced quarterly report
R-Pharm US, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to R-Pharm US
Compare insights from companies similar to R-Pharm US, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$7.2M
11-50
Private
-
-
Company Profile Activity
Activity Insights
R-Pharm US is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
R-Pharm US is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about R-Pharm US.
R-Pharm US Tech Stack
A closer look at the technologies used by R-Pharm US
See more technologies
R-Pharm US News & Media
PsiOxus Therapeutics Appoints Melissa Epperly as Chief Financial Officer
PHILADELPHIA and OXFORD, United Kingdom, June 04, 2018 (GLOBE NEWSWIRE) -- PsiOxus Therapeutics, Ltd. (PsiOxus), a leader in gene therapy for cancer, today announced the appointment of Melissa Epperly as Chief Financial Officer.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding R-Pharm US
Sign Up For FreeTo access detailed company insights
R-PHARM US is a fully integrated specialty pharmaceutical company established in 2014 and located in Princeton, NJ. The company focuses on the development and commercialization of specialty medicines for the treatment of cancer and chronic immune diseases. Notably, R-PHARM US acquired IXEMPRA (ixabepilone) from Bristol-Myers Squibb, successfully tr... Read More
